COMMERCIAL BULLETIN. Inside this issue. Anticoagulants recommended over Aspirin

Size: px
Start display at page:

Download "COMMERCIAL BULLETIN. Inside this issue. Anticoagulants recommended over Aspirin"

Transcription

1 COMMERCIAL BULLETIN Monthly service July 2015 Anticoagulants recommended over Aspirin Patients who suffer from atrial fibrillation (AF) should be prescribed Anticoagulants and not Aspirin says National Institute for health and Care Excellence (NICE). The risks of taking Aspirin (which has been used for years) now outweigh the benefits. Aspirin can cause stomach bleeds. People with AF who have a CHA2DS2-VASC stroke risk score of two or above are offered newer anticoagulants, such as apixaban, dabigatran etexilate, rivaroxaban or a vitamin K antagonist like warfarin. Special points of interest This bulletin is free to Interested people in Pharma & Healthcare Please send names of new subscribers to Jackie@wavedata.co.uk If you have articles, comments or story ideas, please send them to the above Inside this issue Anticoagulants recommended over Aspirin UPDATE on Controlled Drug prescribing PRICE WATCH... UK Bargains offered among recent launches Videos for Pricing Managers New Product-Specific BE Guidance s Forthcoming events Breath test for infection The design of tablets and capsules WaveData Top ten searched products where the focus was to June 2015

2 Page 2 COMMERCIAL BULLETIN UPDATE on Controlled Drug prescribing From July 1 st schedule 2 and 3 CDs can be prescribed [and dispensed] via the Electronic Prescription Service All items on the prescription EXCEPT for the signature can be computer generated EPS release 2 prescriptions for Schedule 2 and 3 controlled drugs will need to satisfy the usual prescription writing requirements including the need to express the total quantity in words and figures. Prescriptions for Schedule 2, 3 and 4 CDs are only valid for 28 days. Schedule 2 and 3 CDs cannot be prescribed on repeat dispensing prescriptions. In the case of owings, the owing balance of prescriptions for Schedule 2, 3 or 4 CDs cannot be dispensed later than 28 days after the appropriate date on the prescription.. To be valid, on top of the normal prescription requirements for prescription only medicines, prescriptions for Schedule 2 and 3 Controlled Drugs must meet certain prescription writing requirements. In summary, these prescriptions must contain the dose, form, strength (where appropriate) and a total quantity of the preparation in both words and figures. NOTE - Although the legislation came in from July 1, actual EPS CD dispensing has to wait until pharmacies using the EPS have had the relevant software upgrade Information provided by Dispex who provide classroom training courses for dispensing doctor practices on all aspects of Controlled Drugs. Sponsorship slots are available contact Dispex on and ask for Greg or gbull@dispex.net for more details. PRICE WATCH... UK Bargains offered among recent launches Half a dozen of our basket of recently-launched products were available at bargain prices last month, after double-digit price falls in their lowest prices. Each bargain, however, was mainly only available from a single source. Just for 56-tablet packs of cilostazol 100mg was the 33% price drop for the lowest price reflected in an average price fall of 15%, suggesting that other suppliers were also cutting their prices (see Figure 1). To see more go to and view our article from this month s Generics Bulletin. WaveData Subscribe to the industry's comprehensive source of news and analysis.

3 Page 3 Videos for Pricing Managers Our managing director Charles Joynson has recently created five more short videos about using pricing plastically using the bppi.co.uk 10 year pricing website. The videos which all start BPPI can be found at: The other videos in the same folder cover: 1. Prescription data (ScriptMap) 2. Patent expiry /loss of exclusivity 3. Analysis of UK retail pricing Wavedata New Product-Specific BE Guidance s New product-specific draft guidance has been released by the FDA The guidance offers recommendations on the design of bioequivalence studies to support ANDAs The documents cover 43 drug products, including some that are still protected from generic competition. The design of tablets and capsules The design of generic tablets and capsules are to be similar in size and shape to their reference listed drug to ensure patient acceptance and compliance, by the FDA. Parameters have been set on how much a generic can vary from its brand counterpart, sized and weights are both factors to be considered.

4 Page 4 Forthcoming events Organizer Date Venue Link or Drug Repurposing Networking Event 20th August 2015 Baroosh, Cambridge EMIG Quarterly Meeting 7th September 2015 London sarah.rogers (at) emig.org.uk EMIG Summit - Biomarkers and Companion Diagnostics for Targeted 9th September 2015 South Kensington Campus sarah.rogers (at) emig.org.uk 18th Annual IGPA Conference Conference on the future of the NHS - with keynote contributions from NHS England, CQC, NHS Alliance, Mind, ADASS and Nuffield Trust Conference on life sciences in the UK - Next steps for UK health life sciences September 2015 Tuesday 20th October nd October GPhA Fall Technical Conference 2-4 November 2015 Toronto, Canada Central London fid=westminster_health_forum Central London North Bethesda, Maryland, US EMIG Parliamentary Dinner 9th November 2015 Westminster How can pressures on the NHS be relieved? 11th November 2015 The Mermaid Theatre, London Chris Sheridan - Digital Sales managher - Tel: +44 (0) EMIG Specialised Commissioning Conference 24th Novemeber 2015 London Conference on next steps for NICE, pharmaceutical industry priorities, and the Accelerated Access Review - Westminster Health Forum Thursday, 14th January 2016 Central London fid=westminster_health_forum The Medical and Scientific group meetings for 2015 Biomarkers and Companion Diagnostics for Targeted Treatments an all-day multi-stakeholder summit at Pinsent Masons Health Economics for the non-health Economist an allday practical workshop with MAP Biopharma and Roboleo 9tth September 2015 London 17th November 2015 London Breath test for infection A breath test has been developed by UK scientists to identify if someone has a bacterial infection. By chemically analysing breath specimens the test can quickly reveal bacterial infection in the lower respiratory tract of ventilated patients in intensive care. The work is still in its early stages, but those involved believe it could have a huge impact on clinical practice.

5 WaveData Top ten searched products where the focus was to June 2015 According to WaveData, these were the most commonly investigated products in searches of the online pricing data Wavedata Live at Both uk and pi prices were viewed for each product, giving some indication of where the focus was to June 2015 WaveData prices in the top 10 article are averages. Product Apr-15 May-15 Jun-15 Seretide Evohaler CFC Free 250mcg 1 (120 Doses) Hydrocortisone Tabs 10mg Metformin Tabs 500mg Lyrica Caps 75mg Mebeverine Tabs 135mg Carbimazole Tabs 5mg Pregabalin Caps 150mg Eplerenone Tabs 25mg Aripiprazole Tabs 10mg Duloxetine E/C Caps 30mg We re on the web! This bulletin now goes out to 3900 plus people. If you would like to add or suggest any articles/comments, please let me know by the 12th August 2015, as I will be issuing the next bulletin on the 19th August 2015 If you have any colleagues who would like to receive this, please let them know about it. You can view all copies of the Bulletin at Jackie Moss WaveData Ltd Jackie@wavedata.co.uk

Commercial bulletin. Special points of interest. Rise in diabetes could bankrupt NHS. Inside this issue: Latest Apple health app.

Commercial bulletin. Special points of interest. Rise in diabetes could bankrupt NHS. Inside this issue: Latest Apple health app. October Monthly service Special points of interest Rise in diabetes could bankrupt NHS More than a million people in the past 10 years have been diagnosed with diabetes, an increase of 60% This bulletin

More information

August NHS could save 517.6m. Diabetes is on the rise.

August NHS could save 517.6m. Diabetes is on the rise. August 2017 Monthly service Commercial bulletin Special points of interest: This bulletin is free to Interested people in Pharma & Healthcare Please send names of new subscribers to Jackie@wavedata.co.uk

More information

Commercial bulletin. Pharmacy Show and CPHI. New pharmaceutical centre creating to new jobs opens in. Hull. Special points of interest:

Commercial bulletin. Pharmacy Show and CPHI. New pharmaceutical centre creating to new jobs opens in. Hull. Special points of interest: Monthly service September 20 Commercial bulletin Special points of interest: This bulletin is free to Interested people in Pharma & Healthcare Please send names of new subscribers to Jackie@wavedata.co.uk

More information

requesting information regarding atrial fibrillation in NHS Ashford Clinical Commissioning Group

requesting information regarding atrial fibrillation in NHS Ashford Clinical Commissioning Group October 2015 Our Ref: FOI.15.ASH0149 requesting information regarding atrial fibrillation in NHS Ashford Clinical Commissioning Group Original Request Survey attached. Question 1: Between 1 July 2014 and

More information

Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG:

Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG: Atrial Fibrillation in Your Area Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG: a) What was the prevalence of atrial fibrillation (AF)? 6636 (as of 22/10/2015) 2.1%

More information

Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)

Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180) Putting NICE guidance into practice Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180) Published: June 2014 This costing report accompanies the clinical

More information

Atrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie

Atrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie Atrial Fibrillation Implementation challenges Lesley Edgar Ross Maconachie Atrial Fibrillation Most common heart rhythm disturbance Rapid and irregular electrical signals Reduced efficiency of blood flow

More information

Atrial fibrillation and anticoagulation therapy

Atrial fibrillation and anticoagulation therapy Atrial fibrillation and anticoagulation therapy This leaflet offers more information about atrial fibrillation for patients who have been advised that they need anticoagulation therapy. If you have any

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1

More information

Plavix eliquis and aspirin

Plavix eliquis and aspirin Plavix eliquis and aspirin The Borg System is 100 % Plavix eliquis and aspirin 273 medications are known to interact with Plavix. Includes amlodipine, aspirin, Aspirin Low Strength ( aspirin ). Eliquis

More information

Volume 9; Number 3 March 2015 PRESCRIBING AND DISPENSING PREGABALIN FOR NEUROPATHIC PAIN

Volume 9; Number 3 March 2015 PRESCRIBING AND DISPENSING PREGABALIN FOR NEUROPATHIC PAIN Arden and Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and

More information

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 pat hways Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs) Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 Options for local implementation NICE

More information

ADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE

ADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE ADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE HELEN WILLIAMS FFRPS, MRPHARMS, PGDIP (CARDIOL) IPRESC CONSULTANT PHARMACIST FOR CVD, SOUTH LONDON CLINICAL LEAD FOR ATRIAL FIBRILLATION, HEALTH INNOVATION

More information

Atrial fibrillation patient decision aid: Antithrombotic therapy

Atrial fibrillation patient decision aid: Antithrombotic therapy Atrial fibrillation patient decision aid: Antithrombotic therapy What this decision aid is for This decision aid is intended to assist health professionals in consultations with patients with atrial fibrillation

More information

Eliquis and plavix combination therapy

Eliquis and plavix combination therapy Eliquis and plavix combination therapy ELIQUIS Dosing for Patients With NVAF. patients treated with aspirin or the combination of bleeding or completion of a course of therapy,. 9-11-2011 Thrombosis is

More information

Coventry Health Care of Georgia, Inc.

Coventry Health Care of Georgia, Inc. Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan

More information

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate Service Notification in response to DHSSPS endorsed NICE Technology Appraisals NICE TA 249: Atrial fibrillation - Dabigatran Etexilate 1 Name of Commissioning Team Long Term Conditions Commissioning Team

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation Thank you for agreeing to give us a statement on your organisation s view of the technology and the way

More information

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you Medicines for stroke prevention in atrial fibrillation Choosing the right one for you Atrial fibrillation (AF) is a condition that affects the heart, causing it to beat irregularly and too fast. When this

More information

National Institute for Health and Clinical Excellence Health Technology Appraisal

National Institute for Health and Clinical Excellence Health Technology Appraisal National Institute for Health and Clinical Excellence Health Technology Appraisal Rivaroxaban for the prevention of venous thromboembolism after elective orthopaedic surgery of the lower limbs Comment

More information

Technician Training Tutorial: Dispensing Oral Blood Thinners

Technician Training Tutorial: Dispensing Oral Blood Thinners (Page 1 of 5) Technician Training Tutorial: Dispensing Oral Blood Thinners Warfarin (Coumadin, Jantoven-U.S., others) is an oral anticoagulant blood thinner used to help prevent blood clots that can lead

More information

TRIPLE THERAPY, NOACs with concurrent indication for DAPT. Paul Wright Lead Cardiac Pharmacist The Heart, UCLH NHS Foundation Trust

TRIPLE THERAPY, NOACs with concurrent indication for DAPT. Paul Wright Lead Cardiac Pharmacist The Heart, UCLH NHS Foundation Trust TRIPLE THERAPY, NOACs with concurrent indication for DAPT Paul Wright Lead Cardiac Pharmacist The Heart, UCLH NHS Foundation Trust Content Why consider triple therapy What we know of triple therapy Current

More information

to a DOAC anticoagulants (DOACs) dosing of DOACs for various indications switching from a DOAC and switching

to a DOAC anticoagulants (DOACs) dosing of DOACs for various indications switching from a DOAC and switching Linda Kelly, PharmD, PhC, CACP Presbyterian Healthcare Services } Identify the FDA approved direct oral anticoagulants (DOACs) } Distinguish the differences in the dosing of DOACs for various indications

More information

Title Patients receiving dabigatran requiring emergency reversal for surgery or treatment of haemorrhage Guidelines. Department.

Title Patients receiving dabigatran requiring emergency reversal for surgery or treatment of haemorrhage Guidelines. Department. Document Control Title Patients receiving dabigatran requiring emergency reversal for surgery or treatment of haemorrhage Guidelines Author Author s job title Pharmacist Directorate PCS - Department Version

More information

Atrial Fibrillation and Anticoagulants

Atrial Fibrillation and Anticoagulants Atrial Fibrillation and Anticoagulants A guide to your diagnosis and treatment Information for patients, relatives and carers For more information, please contact: York Anticoagulant Clinic Tel: 01904

More information

Medicines Optimisation Annual Report Dr Emma Harris and Neil Hardy on behalf of the Medicines Management Team June 2016

Medicines Optimisation Annual Report Dr Emma Harris and Neil Hardy on behalf of the Medicines Management Team June 2016 Medicines Optimisation Annual Report 2015-2016 Dr Emma Harris and Neil Hardy on behalf of the Medicines Management Team June 2016 1 Clinical Objectives Improve the effective use of medicines Maximise health

More information

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended

More information

Hot Topics: Transitions of Care

Hot Topics: Transitions of Care Our quarterly newsletter is a great way to stay up-to-date on emerging clinical information, medication safety issues, and Larkin s Hospital medication policies and procedures. Hot Topics: Transitions

More information

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable)

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Support to patient organisations 2014: (SPONSORSHIP) *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb

More information

National Institute for Health and Clinical Excellence. Single Technology Appraisal (STA)

National Institute for Health and Clinical Excellence. Single Technology Appraisal (STA) National Institute for Health and Clinical Excellence Comment 1: the draft remit Single Technology Appraisal (STA) Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial Response

More information

The first stop for professional medicines advice. Community Pharmacy Oral Anticoagulant Safety Audit

The first stop for professional medicines advice. Community Pharmacy Oral Anticoagulant Safety Audit Community Pharmacy Oral Anticoagulant Safety Audit This audit has been developed with help and support from the following organisations: Community Pharmacy Patient Safety Group PharmOutcomes Pharmaceutical

More information

ASSOCIATE MEMBERSHIP SCHEME

ASSOCIATE MEMBERSHIP SCHEME ASSOCIATE MEMBERSHIP SCHEME INTRODUCTION Dear colleague, I m delighted to launch the NHS Providers Associate Membership Scheme, our brand new offer to commercial suppliers in the health sector. While visiting

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised Name: generic (trade) Dabigatran etexilate (Pradaxa ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised Direct thrombin inhibitor

More information

Show Me the Outcomes!

Show Me the Outcomes! Show Me the Outcomes! Real-World Safety Data on Oral Anticoagulants in Nonvalvular Atrial Fibrillation Gabby Anderson, PharmD PGY1 Pharmacy Resident anderson.gabrielle@mayo.edu Pharmacy Grand Rounds October

More information

Global Anticoagulants Market: Size, Trends & Forecasts ( ) April 2017

Global Anticoagulants Market: Size, Trends & Forecasts ( ) April 2017 Global Anticoagulants Market: Size, Trends & Forecasts (2017-2021) April 2017 Global Anticoagulants Market Scope of the Report The report entitled Global Anticoagulants Market: Size, Trends & Forecasts

More information

Dorset Special Educational Needs and Disabilities (SEND) Communications Strategy. Final version agreed at SEND Delivery Board on 8 January

Dorset Special Educational Needs and Disabilities (SEND) Communications Strategy. Final version agreed at SEND Delivery Board on 8 January Dorset Special Educational Needs and Disabilities (SEND) Communications Strategy Final version agreed at SEND Delivery Board on 8 January 1. Background Dorset County Council and NHS Dorset Clinical Commissioning

More information

Southern Trust Anticoagulant Team

Southern Trust Anticoagulant Team CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Anticoagulation- Primary Care Guidance for reviewing patients on DOACs Southern Trust Anticoagulant Team Haematology Acute

More information

Pharmaceutical System in the UK

Pharmaceutical System in the UK Pharmaceutical System in the UK David Kullman Medicines, i Pharmacy and Industry Group Department of Health PPRI Conference, Vienna 30 September 2011 Disclaimer Conflict of interest: Nothing to disclose

More information

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE HELP GET READY FOR YOUR UPCOMING PROCEDURE READY. SET. DOPTELET. Full Prescribing Information for DOPTELET (avatrombopag), including Patient For adults with chronic liver disease and a low platelet count

More information

stroke.org.uk Atrial Fibrillation Reducing your risk of stroke

stroke.org.uk Atrial Fibrillation Reducing your risk of stroke stroke.org.uk Atrial Fibrillation Reducing your risk of stroke What is AF? Atrial Fibrillation (AF) is the most common type of irregular heartbeat. Over 1 million people in the UK are living with the condition,

More information

What are the risk factors for AF?

What are the risk factors for AF? Susan Mayor was paid in her capacity as a medical writer for her time to research and write this article for Boehringer Ingelheim. This article has been reviewed by Boehringer Ingelheim to ensure compliance

More information

Study period Total sample size (% women) 899 (37.7%) Warfarin Aspirin

Study period Total sample size (% women) 899 (37.7%) Warfarin Aspirin Table S2 Sex- specific differences in oral anticoagulant prescription for stroke prevention in AF Total sample size (% women) Anticoagulant(s) studied Gage (2000) 1 Missouri, USA Discharged during 597

More information

Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation,

Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017 Junya Zhu, PhD Department of Health Policy and Management January 23, 2018 Acknowledgments Co-Authors G.

More information

VOLUNTARY ADMISSION BY BAYER HEALTHCARE

VOLUNTARY ADMISSION BY BAYER HEALTHCARE CASE AUTH/2490/3/12 VOLUNTARY ADMISSION BY BAYER HEALTHCARE Conduct of an employee Bayer Healthcare voluntarily admitted that a healthcare development consultant (HDC) had prepared and used three documents

More information

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Texas Vendor Drug Program Specialty Drug List Process. February 2019 Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed

More information

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting ANTICOAGULANT SERVICE Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting Introduction Fast loading of warfarin carries a risk of over anticoagulation

More information

7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES

7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES 7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES 13-14 June 2018 Dublin, Ireland WHY Since the Avoca Quality Consortium (AQC) launched seven years ago, its mission and purpose has been to

More information

Buprenorphine used in the treatment of opioid dependence: availability and price

Buprenorphine used in the treatment of opioid dependence: availability and price 7 th floor Wellington House 133 155 Waterloo Road London SE1 8UG 24 October 2018 Gateway number: L2018-443 Dear Director of Public Health, Buprenorphine used in the treatment of opioid dependence: availability

More information

requesting information regarding prescribing incentive schemes in Canterbury and Coastal Clinical Commissioning Group

requesting information regarding prescribing incentive schemes in Canterbury and Coastal Clinical Commissioning Group requesting information regarding prescribing incentive schemes in Canterbury and Coastal Clinical Commissioning Group Canterbury and Coastal Clinical Consortium Group Medicine Management plans 2013/14

More information

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts. PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to July 1, 2012. It is intended for information and reference purposes only. This

More information

Blood-thinning medication after stroke

Blood-thinning medication after stroke Stroke Helpline: 0303 3033 100 Website: stroke.org.uk Blood-thinning medication after stroke Blood-thinning medicines are drugs that help to prevent clots forming in your blood. They are often prescribed

More information

Technology appraisal guidance Published: 23 May 2012 nice.org.uk/guidance/ta256

Technology appraisal guidance Published: 23 May 2012 nice.org.uk/guidance/ta256 Rivaroxaban for the prevention ention of stroke and systemic embolism in people with atrial fibrillation Technology appraisal guidance Published: 23 May 2012 nice.org.uk/guidance/ta256 NICE 2018. All rights

More information

Agenda Item No. 8a SERVICE SPECIFICATION. 1. Introduction:

Agenda Item No. 8a SERVICE SPECIFICATION. 1. Introduction: SERVICE SPECIFICATION Agenda Item No. 8a Service Specification No. Service Atrial Fibrillation Audit patient reviews Commissioner Lead Caroline Davidson Period 1 st September to 31 st March 2017 Date of

More information

AHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke. Version: 13 March 2017

AHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke. Version: 13 March 2017 AHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke Version: 13 March 2017 Introduction This business case template has been created so that

More information

OUR GOALS. For the detailed plan visit

OUR GOALS. For the detailed plan visit STRATEGIC PRIORITIES When organizations reach milestones such as a golden anniversary, leadership should not only seize the opportunity to revel in past successes, but also proceed with a renewed focus

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Oral Anticoagulants Page 1 of 7 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Oral Anticoagulant - Bevyxxa (betrixaban), Eliquis (apixaban), Pradaxa (dabigatran),

More information

DOAC the story so far... Dr GM Benson Director NI Haemophilia and Thrombosis Centre BHSCT

DOAC the story so far... Dr GM Benson Director NI Haemophilia and Thrombosis Centre BHSCT DOAC the story so far... Dr GM Benson Director NI Haemophilia and Thrombosis Centre BHSCT A rose by any other name.. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC

More information

Guide to Interchangeable Medicines

Guide to Interchangeable Medicines Guide to Interchangeable Medicines AUT-G0115-6 01 JUNE 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 BACKGROUND 3 1.1

More information

Fibrillation. Living. withatrial. Further information

Fibrillation. Living. withatrial. Further information Further information Anticoagulation UK is committed to the prevention of thrombosis and to providing information and support to help people maintain their quality of life whilst on anticoagulant or antiplatelet

More information

Alison Tennant MRPharmS MPH Head of Service Improvement and Quality Dudley CCG

Alison Tennant MRPharmS MPH Head of Service Improvement and Quality Dudley CCG Alison Tennant MRPharmS MPH Head of Service Improvement and Quality Dudley CCG Commissioning is the set of linked activities required to assess the healthcare needs of a population, specify the services

More information

Aspirin versus pradaxa

Aspirin versus pradaxa Search Search Aspirin versus pradaxa 14-12-2012 Dabigatran (Pradaxa): Good news on safety but caution still warranted. the risk of bleeding versus the risk. (Aspirin and other inhibitors of. 15-12-2008

More information

New options in Stroke Prevention in AF Paul Dorian University of Toronto St Michael s Hospital

New options in Stroke Prevention in AF Paul Dorian University of Toronto St Michael s Hospital New options in Stroke Prevention in AF Paul Dorian University of Toronto St Michael s Hospital Disclosures: Honoraria, research support, and consulting f Sanofi, Boehringer-Ingleheim, Portola, BMS, Bayer,

More information

18/09/2012. Dr. Khalid Khan Consultant Cardiologist BCUHB. Oral Anticoagulation Update Day 12 th September 2012 University of Birmingham

18/09/2012. Dr. Khalid Khan Consultant Cardiologist BCUHB. Oral Anticoagulation Update Day 12 th September 2012 University of Birmingham Dr. Khalid Khan Consultant Cardiologist BCUHB Oral Anticoagulation Update Day 12 th September 2012 University of Birmingham 1 NICE vs. Local Guidance NICE says no We say no NICE says yes We say no NOACs

More information

Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University

Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University Disclosures Research Grants and speaking fees St. Jude

More information

NEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS

NEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS NEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS OBJECTIVES: To provide a comparison of the new/novel oral anticoagulants (NOACs) currently available in Canada. To address

More information

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Harmonization effort for OTC monograph in Taiwan Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Outline Background OTC drug registration OTC monographs Future directions

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely

More information

Updates in Atrial Fibrillation

Updates in Atrial Fibrillation Updates in Atrial Fibrillation Michael Curley, MD Cardiac Electrophysiologist Wheaton Franciscan Medical Group #1 Most common heart rhythm disturbance 1 in 4 Americans over 40 will be diagnosed 3,500,000

More information

the best of care Managing diabetes with the FORA Diamond MINI and tools from Discovery Health Medical Scheme

the best of care Managing diabetes with the FORA Diamond MINI and tools from Discovery Health Medical Scheme the best of care 2014 Managing diabetes with the FORA Diamond MINI and tools from Discovery Health Medical Scheme contents What this document is about This document gives an overview of the FORA Diamond

More information

Costing statement: Atrial fibrillation and heart valve disease: selfmonitoring coagulation status using point-of-care coagulometers (the CoaguChek XS)

Costing statement: Atrial fibrillation and heart valve disease: selfmonitoring coagulation status using point-of-care coagulometers (the CoaguChek XS) Putting NICE guidance into practice Costing statement: Atrial fibrillation and heart valve disease: selfmonitoring coagulation status using point-of-care coagulometers (the CoaguChek XS) Published: September

More information

A2.1: Main model assumptions

A2.1: Main model assumptions Appendix 2: Main assumptions and structure of the economic model We assumed that before the introduction of DOACs standard of care for AF patients was warfarin. For patients on warfarin as first-line treatment,

More information

IMMEDIATE DICLOFENAC NEW CONTRAINDICATIONS AND WARNINGS AFTER A EUROPE-WIDE REVIEW OF CARDIOVASCULAR SAFETY

IMMEDIATE DICLOFENAC NEW CONTRAINDICATIONS AND WARNINGS AFTER A EUROPE-WIDE REVIEW OF CARDIOVASCULAR SAFETY Finance, EHealth and Pharmaceuticals Directorate Pharmacy and Medicines Division T: 0131-244 2528 E: irene.fazakerley@scotland.gsi.gov.uk 1. Medical Directors 2. Directors of Public Health 3. Directors

More information

Update to HMO Drug Formulary Tier Definitions. February 8, 2018

Update to HMO Drug Formulary Tier Definitions. February 8, 2018 Update to HMO Drug Formulary Tier Definitions February 8, 2018 Agenda 1 Overview of Current Drug Tiers 2 Proposed Drug Tiers for 2019 3 Impact to SFHSS and SFHSS Members 4 How the Drug Formulary Works

More information

Lincolnshire Prescribing and Clinical Effectiveness Bulletin

Lincolnshire Prescribing and Clinical Effectiveness Bulletin S Lincolnshire Prescribing and Clinical Effectiveness Bulletin Volume 12 No 10, November 2018 Optum in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services,

More information

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) after hip or knee replacement surgery Always read the

More information

Technology appraisal guidance Published: 23 September 2015 nice.org.uk/guidance/ta355

Technology appraisal guidance Published: 23 September 2015 nice.org.uk/guidance/ta355 Edoxaban for preventing enting stroke and systemic embolism in people with non- valvular atrial fibrillation Technology appraisal guidance Published: 23 September 2015 nice.org.uk/guidance/ta355 NICE 2015.

More information

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services To: Health and justice commissioners and providers Public Health England health and justice leads Her Majesty s Prison and Probation Service Home Office immigration removal centre leads Health and justice

More information

Management of haemorrhage in patients taking DOACs/ NOACs (direct/ novel oral anticoagulants) Guideline. Contents

Management of haemorrhage in patients taking DOACs/ NOACs (direct/ novel oral anticoagulants) Guideline. Contents Management of haemorrhage in patients taking DOACs/ NOACs (direct/ novel oral anticoagulants) Guideline Classification: Clinical Guideline Lead Author: Dr Rowena Thomas-Dewing, Consultant Haematologist

More information

Initial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care

Initial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care Initial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care 11 th and 25 th September 2014 3 KEY OBJECTIVES OF TALK 1.

More information

The Society welcomes the opportunity to respond the Department of Health s consultation on generic substitution.

The Society welcomes the opportunity to respond the Department of Health s consultation on generic substitution. Lindsey Gilpin Chairman of the English Pharmacy Board Telephone: 020 7572 2519 Fax: 0207 572 2501 e-mail: howard.duff@rpsgb.org 25 th March 2010 Dear Sir/Madam, Consultation on the proposals to implement

More information

CV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09

CV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09 CV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09 Dr Ameet Bakhai, FRCP Cardiologist, Clinical Trials, Health Economics Barnet & Chase Farm NHS Trust Royal Free

More information

IAPP KnowledgeNet Chapter Chair Manual 2018

IAPP KnowledgeNet Chapter Chair Manual 2018 IAPP KnowledgeNet Chapter Chair Manual 2018 CHAIR ROLES & EXPECTATIONS IAPP RESPONSIBILITIES PLANNING A CHAPTER MEETING INFORMATION & TIPS FOR HOST VENUE INFORMATION & TIPS FOR SPEAKERS OTHER CHAPTER VOLUNTEERS

More information

Proposal on subsidy changes for some respiratory inhalation products and access restrictions to combination inhalers.

Proposal on subsidy changes for some respiratory inhalation products and access restrictions to combination inhalers. 30 August 2011 Proposal on changes for some respiratory products and access restrictions to combination inhalers. As notified on 16 June 2011, PHARMAC has been considering options for managing the funding

More information

Bayer s Rivaroxaban Demonstrated Superior Protection Against Recurrent Venous Thromboembolism Compared with Aspirin in EINSTEIN CHOICE Study

Bayer s Rivaroxaban Demonstrated Superior Protection Against Recurrent Venous Thromboembolism Compared with Aspirin in EINSTEIN CHOICE Study News Release Not intended for U.S. and UK Media Bayer AG Communications and Public Affairs 51368 Leverkusen Germany Tel. +49 214 30-0 www.news.bayer.com New Late-Breaking Study Data Presented at ACC.17:

More information

North East Essex Medicines Management Committee

North East Essex Medicines Management Committee Colchester Hospital University NHS Foundation Trust North East Essex Clinical Commissioning Group North East Essex Medicines Management Committee ORAL ANTICOAGULANT (Vit K antagonist only) MANAGEMENT GUIDELINES

More information

Oxford Centre for Respiratory Medicine Ultrasound guided pleural biopsy Information for patients

Oxford Centre for Respiratory Medicine Ultrasound guided pleural biopsy Information for patients Oxford Centre for Respiratory Medicine Ultrasound guided pleural biopsy Information for patients Provisional appointment date and time.... Important information about your ultrasound guided pleural biopsy

More information

Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery

Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery Issue date: May 2005 Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery Understanding NICE guidance information for people considering the procedure, and for the

More information

Atrial Fibrillation Collaborative. Thursday 7 May 2015

Atrial Fibrillation Collaborative. Thursday 7 May 2015 Atrial Fibrillation Collaborative Thursday 7 May 2015 Welcome and introductions Peter Carpenter KSS AHSN Nicky Jonas SEC CVD SCN AF Project Support KSS Academic Health Science Network & South East Cardiovascular

More information

Mental Health Charter for Sport and Recreation

Mental Health Charter for Sport and Recreation Mental Health Charter for Sport and Recreation As a signatory of the Mental Health Charter for Sport and Recreation we are committed to taking action across the following six areas: 1. Use our sport to

More information

SPONSORSHIP OPPORTUNITIES

SPONSORSHIP OPPORTUNITIES CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on n Biomarkers and Cancer Targets December 05-06, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme

More information

National Diabetes Inpatient Audit (NaDIA) 2016

National Diabetes Inpatient Audit (NaDIA) 2016 National Diabetes Inpatient Audit (NaDIA) 2016 DIABETES A summary report for people with diabetes and anyone interested in the quality of care for people with diabetes when they stay in hospital. Based

More information

Pradaxa. [dabigatran etexilate] patient support booklet

Pradaxa. [dabigatran etexilate] patient support booklet Pradaxa [dabigatran etexilate] patient support booklet Important information about your medication and how to take it to help you reduce your risk of stroke associated with atrial fibrillation You have

More information

Warfarin & You By V. B. Blake

Warfarin & You By V. B. Blake Warfarin & You By V. B. Blake Warfarin is an anticoagulant used to to prevent heart attacks, strokes, and blood clots. Learn about side effects, interactions and indications. Can you tell me what I should

More information

NOACS/DOACS*: COMPARISON AND FREQUENTLY-ASKED QUESTIONS

NOACS/DOACS*: COMPARISON AND FREQUENTLY-ASKED QUESTIONS NOACS/DOACS*: COMPARISON AND FREQUENTLY-ASKED QUESTIONS OBJECTIVES: To provide a comparison of the newer direct oral anticoagulants (DOACs) currently available in Canada. To address frequently-asked questions

More information

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

Report. Uganda Pharmaceutical Sector Scan JUNE 2010 Report On the Uganda Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments JUNE 2010 Drafted by consultants: 1. Samuel Balyejjusa, B.Pharm., MPH 2. Paschal Mujasi, B.Pharm., MBA 3.

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

PRESENTATION TITLE. Case Studies

PRESENTATION TITLE. Case Studies PRESENTATION TITLE Case Studies 1) SH is a 67 year old male. He has a history of type 2 diabetes, controlled hypertension and peripheral artery disease. He takes naproxen 500mg bd for arthritis and admits

More information

Apixaban for stroke prevention in atrial fibrillation. August 2010

Apixaban for stroke prevention in atrial fibrillation. August 2010 Apixaban for stroke prevention in atrial fibrillation August 2010 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to

More information

Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin

Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin Objectives What is FMD all about and when does it need to happen? Who are SecurMed and what is our role

More information

American College of Cardiology 66th Annual Scientific Session (ACC.17):

American College of Cardiology 66th Annual Scientific Session (ACC.17): News Release Not intended for U.S. and UK Media Bayer AG Communications and Public Affairs 51368 Leverkusen Germany Tel. +49 214 30-0 www.news.bayer.com American College of Cardiology 66th Annual Scientific

More information